A patient recently started on corticosteroids presents with daily vomiting, epigastric pain, normal amylase, and laboratory findings of elevated bilirubin, elevated alkaline phosphatase, and markedly elevated AST and ALT. What is the appropriate next step in management?

Immediate Management of Corticosteroid-Associated Hepatocellular Injury

This patient has severe hepatocellular injury (AST 501, ALT 667—approximately 15-20x upper limit of normal) with cholestatic features (bilirubin 3, ALP 261) temporally related to corticosteroid initiation, requiring immediate discontinuation of steroids, urgent right upper quadrant ultrasound to exclude biliary obstruction, and close monitoring for acute liver failure. 1, 2

Immediate Actions

Discontinue the Offending Agent

• Stop corticosteroids immediately. Drug-induced liver injury from corticosteroids, though rare, can progress to acute liver failure with AST/ALT levels exceeding 10,000-18,000 IU/L if the medication is continued 2
• The temporal relationship (symptoms began after steroid initiation) and severity of transaminase elevation strongly suggest drug-induced hepatotoxicity 2, 3

Obtain Urgent Imaging

• Order right upper quadrant ultrasound with Doppler immediately to exclude biliary obstruction, assess for hepatic vein thrombosis, and evaluate liver parenchyma 1
• The pattern shows mixed hepatocellular-cholestatic injury (elevated transaminases with elevated bilirubin and ALP), which requires imaging to exclude mechanical obstruction despite the predominant hepatocellular pattern 1, 3

Risk Stratification

Assess for Acute Liver Failure

• Check INR/PT and albumin immediately as these reflect actual hepatic synthetic function, not just injury 1, 3
• Monitor for altered mental status, as acute liver failure can develop rapidly with corticosteroid-induced hepatotoxicity 2
• The combination of severe transaminase elevation (>10x upper limit) with hyperbilirubinemia places this patient at risk for progression 2, 3

Severity Classification

• This represents severe hepatocellular injury (ALT 667 is >10 times the upper reference limit of ~30 IU/L for women) 1, 3
• The elevated conjugated bilirubin (total bilirubin 3) with hepatocellular injury suggests significant hepatic dysfunction 3

Diagnostic Workup

Exclude Alternative Etiologies

While corticosteroids are the likely culprit, obtain:

• Hepatitis A, B, C serologies (anti-HAV IgM, HBsAg, anti-HBc IgM, anti-HCV with reflex HCV RNA) 3
• Autoimmune markers: ANA, anti-smooth muscle antibody, immunoglobulins—particularly important since the patient was empirically started on steroids, which can paradoxically worsen autoimmune hepatitis if inadequately dosed or cause hepatotoxicity themselves 2, 3
• Acetaminophen level given the vomiting and potential for inadvertent overdose with combination analgesics 3
• Right upper quadrant ultrasound with Doppler to assess biliary tree, hepatic vasculature, and liver parenchyma 1

Additional Testing if Initial Workup Negative

• Ceruloplasmin (Wilson's disease), ferritin and transferrin saturation (hemochromatosis), alpha-1 antitrypsin level and phenotype 3
• Review all medications including over-the-counter supplements, as polypharmacy increases hepatotoxicity risk 3

Monitoring Strategy

Intensive Surveillance

• Repeat liver chemistries, INR, and albumin within 24-48 hours to assess trajectory 2, 3
• If transaminases continue rising or INR becomes elevated, consider transfer to a facility with transplant capability 2
• Monitor for clinical deterioration: worsening encephalopathy, coagulopathy, or rising bilirubin despite steroid cessation 2

Expected Course

• With corticosteroid discontinuation, liver function typically improves within days to weeks 2
• Failure to improve or worsening parameters after stopping steroids necessitates liver biopsy consideration and hepatology consultation 2, 3

Critical Pitfalls to Avoid

Do Not Continue or Restart Steroids

• Rechallenge with corticosteroids can precipitate fulminant hepatic failure, as demonstrated in case reports where AST/ALT increased to 18,000/12,000 IU/L upon re-exposure 2
• Even if the initial indication for steroids was autoimmune hepatitis, the dramatic worsening with steroid exposure indicates drug-induced injury rather than undertreated autoimmune disease 2

Do Not Delay Imaging

• The cholestatic component (elevated ALP and bilirubin) requires exclusion of biliary obstruction, even though the predominant pattern is hepatocellular 1, 3
• Ultrasound is the appropriate initial imaging modality for this presentation 1

Address the GI Symptoms Appropriately

• The normal amylase makes pancreatitis less likely, but does not exclude it entirely 4
• Continue PPI (Protonix) and sucralfate for gastroprotection, but recognize these treat symptoms, not the underlying hepatic injury 3
• The vomiting and epigastric pain may reflect hepatic distension or associated gastritis, which should improve with steroid cessation 2